BioCentury
ARTICLE | Clinical News

RedHill preclinical data

August 5, 2013 7:00 AM UTC

In an animal model of collagen-induced arthritis (CIA), RedHill said RHB-104 significantly reduced disease severity. The company plans to start a Phase IIa trial of RHB-104 to treat RA, but declined t...